Angiocol™, the recombinant α2 NC1 domain from human collagen type-IV inhibits experimental melanoma metatasis in vivo.

被引：0
|
作者：
Prestayko, A
Boutaud, A
Hudson, BG
Jones, D
Roth, J
Kim, J
Brooks, PC
机构：
[1] BioStratum Inc, Durham, NC USA
[2] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
[3] NYU, Sch Med, New York, NY USA
来源：
CLINICAL CANCER RESEARCH | 2001年 / 7卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
20
引用
收藏
页码：3657S / 3657S
页数：1
相关论文
共 50 条
  • [1] CRYSTALS OF THE NC1 DOMAIN OF HUMAN TYPE-IV COLLAGEN
    STUBBS, M
    SUMMERS, L
    MAYR, I
    SCHNEIDER, M
    BODE, W
    HUBER, R
    RIES, A
    KUHN, K
    JOURNAL OF MOLECULAR BIOLOGY, 1990, 211 (04) : 683 - 684
  • [2] The NC1 domain of type XIX collagen inhibits in vivo melanoma growth
    Ramont, Laurent
    Brassart-Pasco, Sylvie
    Thevenard, Jessica
    Deshorgue, Aurelie
    Venteo, Lydie
    Laronze, Jean Yves
    Pluot, Michel
    Monboisse, Jean-Claude
    Maquart, Francois-Xavier
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (02) : 506 - 514
  • [3] COMPARISON OF NC1 DOMAIN OF TYPE-IV COLLAGEN ISOLATED FROM HUMAN GBM AND EHS TUMOR
    KLEPPEL, MM
    MICHAEL, AF
    FISH, AJ
    FEDERATION PROCEEDINGS, 1985, 44 (04) : 1064 - 1064
  • [4] THE FUNCTION OF THE NC1 DOMAINS IN TYPE-IV COLLAGEN
    RIES, A
    ENGEL, J
    LUSTIG, A
    KUHN, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) : 23790 - 23794
  • [5] Role of the NC1 domain of type IV collagen in vascular basement membrane assembly:: Implications for the mechanism of action of Angiocol™, the recombinant α2 NC1 domain, a potent anti-angiogenic agent.
    Borza, D
    Bondar, O
    Hudson, BG
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3661S - 3661S
  • [6] The NC1 domain of type XIX collagen inhibits melanoma cell migration
    Toubal, Aida
    Ramont, Laurent
    Terryn, Christine
    Brassart-Pasco, Sylvie
    Patigny, Dominique
    Sapi, Janos
    Monboisse, Jean-Claude
    Maquart, Francois-Xavier
    EUROPEAN JOURNAL OF DERMATOLOGY, 2010, 20 (06) : 712 - 718
  • [7] ABNORMALITIES IN THE NC1 DOMAIN OF COLLAGEN TYPE-IV IN GBM IN CANINE HEREDITARY NEPHRITIS
    THORNER, P
    BAUMAL, R
    VALLI, VEO
    MAHURAN, D
    MCINNES, R
    MARRANO, P
    KIDNEY INTERNATIONAL, 1989, 35 (03) : 843 - 850
  • [8] Crystal structure of Angiocol™ and other noncollagenous (NC1) domains of type IV collagen.
    Sundaramoorthy, M
    Meiyappan, M
    Govindaraj, S
    Todd, P
    Hudson, BG
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3656S - 3656S
  • [9] THE ROLE OF THE MAIN NONCOLLAGENOUS DOMAIN (NC1) IN TYPE-IV COLLAGEN SELF-ASSEMBLY
    TSILIBARY, EC
    CHARONIS, AS
    JOURNAL OF CELL BIOLOGY, 1986, 103 (06): : 2467 - 2473
  • [10] THE EFFECT OF NONENZYMATIC GLUCOSYLATION ON THE BINDING OF THE MAIN NONCOLLAGENOUS NC1 DOMAIN TO TYPE-IV COLLAGEN
    TSILIBARY, EC
    CHARONIS, AS
    REGER, LA
    WOHLHUETER, RM
    FURCHT, LT
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1988, 263 (09) : 4302 - 4308
12345